Skip to content

Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia

Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) as Additional Endoscopic Treatment Options for Achalasia and Other Esophageal Motility Disorders

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02518542
Acronym
POETA
Enrollment
400
Registered
2015-08-10
Start date
2014-06-30
Completion date
2027-06-30
Last updated
2015-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Achalasia

Brief summary

Achalasia is an esophageal motility disorder, which leads to clinical symptoms such as dysphagia, regurgitation, chest pain and consecutive weight loss. Although conventional treatment such as laparoscopic Heller myotomy (LHM) and balloon dilatation (BD) can provide sufficient symptom relief in many patients, both interventions have their individual drawbacks. Additionally, treatment after failed LHM or BD can be challenging and in few might even lead to esophagectomy. Per oral endoscopic myotomy (POEM) and prolonged dilatation (PRD) are two novel endoscopically performed therapeutic options for achalasia and other esophageal motility disorders. Both not only appear to provide good results, when performed as initial treatment but also might be an excellent option after e.g failed LHM. The purpose of this study is to evaluate the long-term efficacy of four different treatment options, such as POEM, PRD with stent-fixation, PD and conventional LHM for achalasia in an individualized treatment setting.

Interventions

PROCEDUREEndoscopic intervention A

POEM: Per oral endoscopic myotomy

PROCEDUREEndoscopic intervention B

PRD: Prolonged dilatation by temporary implantation of large diameter stent . Stents are additionally attached to the esophageal wall by different technical options.

PROCEDUREEndoscopic intervention C

Endoscopic balloon dilatation

PROCEDURELaparoscopic Surgery

Laparoscopic Heller myotomy

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of achalsia, hypertensive lower esophageal sphincter, nutcracker esophagus, or diffuse esophageal spasm

Exclusion criteria

* Contraindication for EGD

Design outcomes

Primary

MeasureTime frameDescription
Achalasia specific symptoms according to the Eckardt score (0-12)6 mo post-opEckardt score: Weight loss 0kg (0), less than 5kg (1), 5-10 kg (2), more than 10 kg (3); Dysphagia none(0), occasional (1), daily (2), every meal (3); Regurgitation none(0), occasional (1), daily (2), every meal (3); Retrosternal pain none(0), occasional (1), daily (2), every meal (3)

Secondary

MeasureTime frameDescription
Barium column height (cm) in esophagogram6 mo post-op
Resting pressure (mmHg) at the lower esophageal sphincter6 mo post-op
Stent migrationp.o. day 1Analysis: On the first postoperative day a routine esophagogram will be used to evaluate the appropriate location of the esophageal stent. Early distal stent dislocation/migration into the stomach will be registered.
Percent of time (min)/24h that the pH is less than 4.0 in pH-metry6 mo post-op

Countries

Austria

Contacts

Primary ContactDepartment of Surgery, Medical University of Vienna
sebastian.schoppmann@meduniwien.ac.at; erwin.rieder@meduniwien.ac.at+43 1 40400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026